Abstract
Monitoring adds assurance that during routine commercial production of drug products, the process remains in a state of control. Through life cycle Stage 1, critical material attributes and CQAs are established; critical process parameters (CPPs) and process control strategies are defined. CPPs and CQAs are verified in Stage 2. As the product moves to Stage 3, the body of data grows significantly. At Stage 3A and 3B, CPV data continues to be generated until the product is discontinued. As data is available in real time, it allows immediate action for continuous improvement upon signal detection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
US FDA. Guideline on general principles of process validation. Rockville: FDA; 1987.
US FDA. 2011. https://www.fda.gov/downloads/drugs/guidances/ucm070336.pdf.
EMA. Guideline on process validation for finished products – information and data to be provided in regulatory submissions. London: EMA; 2016.
Alsmeyer D, Pazhayattil A. A case for stage 3 continued process verification. Pharma Manuf. 2014. https://www.pharmamanufacturing.com/articles/2014/stage3-continued-process-verification/.
Pazhayattil A. Integrating PV lifecycle approach to a global organization, PDA annual meeting. 2018.
Sayeed-Desta N, Pazhayattil AB, Collins J, Chen S, Ingram M, Spes J. Assessment methodology for process validation lifecycle stage 3A. AAPS PharmSciTech. 2017;18:1881–6.
Best M, Neuhauser D. Walter A Shewhart, 1924, and the Hawthorne factory. Qual Saf Health Care. 2006;15(2):142–3.
Pazhayattil A. Annual product reviews: how to conduct an effective annual product quality review. Pharma Manuf. 2012. https://www.pharmamanufacturing.com/articles/2012/018/.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Pazhayattil, A.B., Sayeed-Desta, N., Fredro-Kumbaradzi, E., Collins, J. (2018). Stage 3A and Stage 3B: Continued Process Verification. In: Solid Oral Dose Process Validation. AAPS Introductions in the Pharmaceutical Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-02472-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-02472-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02471-0
Online ISBN: 978-3-030-02472-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)